drugset / Trial / NCT00263549

Safety and Efficacy of House Dust Mite Allergen Extract in the Treatment of Allergic Rhinoconjunctivitis

NCT00263549 ↗

Phase 4 Completed Allergopharma GmbH & Co. KG
RandomizedParallel-groupDouble-blindTreatment

Summary

The trial is performed to assess efficacy and safety of Novo-Helisen Depot in allergic Rhinoconjunctivitis

Timeline

Start
2002-09
Primary completion
2005-02
Completion
2006-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Novo Helisen Depot Other / unclassified — —